Literature DB >> 23551063

A high throughput assay for the glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin by recombinant human UDP-glucuronosyltransferases and liver microsomes.

Tuomas Rahikainen1, Merja R Häkkinen, Moshe Finel, Markku Pasanen, Risto O Juvonen.   

Abstract

1. UDP-glucuronosyltransferases (UGTs) are versatile and important conjugation enzymes in the metabolism of drugs and other xenobiotics. 2. We have developed a convenient quantitative multi-well plate assay to measure the glucuronidation rate of 7-hydroxy-4-trifluoromethylcoumarin (HFC) for several UGTs. 3. We have used this method to screen 11 recombinant human UGTs for HFC glucuronidation activity and studied the reaction kinetics with the most active enzymes. We have also examined the HFC glucuronidation activity of liver microsomes from human, pig, rabbit and rat. 4.  At a substrate concentration of 20 µM, the most active HFC glucuronidation catalysts were UGT1A10 followed by UGT1A6 >UGT1A7 >UGT2A1, whereas at 300 µM UGT1A6 was about 10 times better catalyst than the other recombinant UGTs. The activities of UGTs 1A3, 1A8, 1A9, 2B4 and 2B7 were low, whereas UGT1A1 and UGT2B17 exhibited no HFC glucuronidation activity. UGT1A6 exhibited a significantly higher Vmax and Km values toward both HFC and UDP-glucuronic acid than the other UGTs. 5. Human, pig and rabbit, but not rat liver microsomes, catalyzed HFC glucuronidation at high rates. 6. This new method is particularly suitable for fast activity screenings of UGTs 1A6, 1A7, 1A10 and 2A1 and HFC glucuronidation activity determination from various samples.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23551063     DOI: 10.3109/00498254.2013.783724

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  7 in total

Review 1.  Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives.

Authors:  Qiang Jin; JingJing Wu; Yue Wu; Hongxin Li; Moshe Finel; Dandan Wang; Guangbo Ge
Journal:  Acta Pharm Sin B       Date:  2022-01-21       Impact factor: 14.903

2.  Quantitative ADME proteomics - CYP and UGT enzymes in the Beagle dog liver and intestine.

Authors:  Aki T Heikkinen; Arno Friedlein; Mariette Matondo; Oliver J D Hatley; Aleksanteri Petsalo; Risto Juvonen; Aleksandra Galetin; Amin Rostami-Hodjegan; Ruedi Aebersold; Jens Lamerz; Tom Dunkley; Paul Cutler; Neil Parrott
Journal:  Pharm Res       Date:  2014-07-18       Impact factor: 4.200

3.  In vitro sulfonation of 7-hydroxycoumarin derivatives in liver cytosol of human and six animal species.

Authors:  Risto O Juvonen; Olli Pentikäinen; Juhani Huuskonen; Juri Timonen; Olli Kärkkäinen; Aki Heikkinen; Muluneh Fashe; Hannu Raunio
Journal:  Xenobiotica       Date:  2020-01-08       Impact factor: 1.908

Review 4.  Coumarin-Based Profluorescent and Fluorescent Substrates for Determining Xenobiotic-Metabolizing Enzyme Activities In Vitro.

Authors:  Hannu Raunio; Olli Pentikäinen; Risto O Juvonen
Journal:  Int J Mol Sci       Date:  2020-07-01       Impact factor: 5.923

5.  Molecular Docking-Based Design and Development of a Highly Selective Probe Substrate for UDP-glucuronosyltransferase 1A10.

Authors:  Risto O Juvonen; Sanna Rauhamäki; Sami Kortet; Sanna Niinivehmas; Johanna Troberg; Aleksanteri Petsalo; Juhani Huuskonen; Hannu Raunio; Moshe Finel; Olli T Pentikäinen
Journal:  Mol Pharm       Date:  2018-02-15       Impact factor: 4.939

6.  Enterohepatic Circulation and Pharmacokinetics of Genistin and Genistein in Rats.

Authors:  Ya-Yu Yang; Tung-Hu Tsai
Journal:  ACS Omega       Date:  2019-10-24

7.  Enhanced Activity of P4503A4 and UGT1A10 Induced by Acridinone Derivatives C-1305 and C-1311 in MCF-7 and HCT116 Cancer Cells: Consequences for the Drugs' Cytotoxicity, Metabolism and Cellular Response.

Authors:  Monika Pawłowska; Anna Kwaśniewska; Zofia Mazerska; Ewa Augustin
Journal:  Int J Mol Sci       Date:  2020-05-31       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.